This week isn’t packed with blockbuster events, but a few key reports could shift how investors see big tech and the broader economy. Nvidia’s results on Wednesday will likely steal the spotlight, as the company’s massive lead in AI chips makes it a test case for whether sky-high AI investments are
A Canadian company is making waves in the crowded field of metabolic disease treatments. SureNano Science, once focused on food-grade chemicals, is now shifting gears toward pharmaceuticals. Their latest move? A feature in a biotech news outlet highlighting their experimental drug, GEP-44. This pept
A fresh look at a large medical record review points to a possible link between GLP‑1 drugs and better long‑term outcomes for breast cancer patients. The research, published in a respected medical journal on May 11, examined nearly eight thousand women who received a breast cancer diagnosis betwe
Weight loss medications like Ozempic and Wegovy have helped many people shed pounds, but a hidden cost might be waiting. New research shows people often judge those who use these drugs more harshly than those who lose weight through diet and exercise. In one study, over 1, 300 participants ranked a
Over the last year, Alphabet has quietly built a strong lead in artificial intelligence, covering everything from cloud computing to research. Now, it’s close to passing Nvidia as the world’s most valuable company. This shift shows how AI isn’t just changing tech—it’s reshaping which firms come out
Seattle’s newest school chief, Ben Shuldiner, rolled out a statewide ban on cellphones in elementary and middle schools just three months after taking the job. The rule stops students from using phones from bell to bell, while high‑schoolers can keep them during lunch and passing times. The decision
Omada Health has joined forces with Eli Lilly’s Employer Connect program, stepping in as an independent manager of a new weight‑loss medication pathway. The partnership lets employers give employees access to the GLP‑1 Care Track, which covers medical checks, prescriptions and ongoing drug monitorin
Schools today aren’t just teaching algebra or history—they’re preparing students for a world where phones are everywhere. A complete ban on these devices might seem like an easy fix for distractions, but it ignores a bigger issue: teaching responsible use instead of avoiding technology altogether. T
New research digs into how long someone has epilepsy and whether it affects their brain’s waste removal system. Using a special brain scan called DTI-ALPS, scientists measured how efficiently fluid moves through the brain’s tiny cleaning tunnels. They found that the longer epilepsy lasts, the more t
Ashley Graham isn't backing down from her body-positive message even as GLP-1 drugs like Ozempic and Wegovy flood social media. The 38-year-old model admits the trend hits hard for women who spent years fighting to love their bodies exactly as they are. "It feels like a step backward, " she explains
